PRCT — what changed in the latest 10-Q
A section-by-section comparison of PRCT's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-05 vs the prior 10-Q · 2026-04-30
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +9 | −8 | ~20 | 36 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~1 | 0 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 2 |
| Legal proceedings | Text added/removed | +3 | −1 | 0 | 0 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-05
Comparison of Three and Six Months Ended June 30, 2026 and 2025
Revenue increased $15.3 million, or 19%, to $94.5 million during the three months ended June 30, 2026, compared to $79.2 million during the three months ended June 30, 2025, and increased $29.3 million or 20% to $177.6 million during the six months ended June 30, 2026, compared to $148.3 million dur…
Cost of sales increased $4.7 million, or 17%, to $32.1 million during the three months ended June 30, 2026, compared to $27.4 million during the three months ended June 30, 2025, and increased $8.9 million or 17% to $61.3 million during the six months ended June 30, 2026, compared to $52.4 million d…
Gross margin increased to 66% during the three months ended June 30, 2026, compared to 65% for the three months ended June 30, 2025, and remained flat at 65% during the six months ended June 30, 2026, compared to the six months ended June 30, 2025. The year over year increase in gross margin was pri…
R&D expenses increased $2.5 million, or 14%, to $20.1 million during the three months ended June 30, 2026, compared to $17.6 million during the three months ended June 30, 2025 and increased $7.5 million or 22% to $41.6 million during the six months ended June 30, 2026, compared to $34.0 million dur…
Text removed vs the prior filing · source: 10-Q · 2026-04-30
Revenue increased $14.0 million, or 20%, to $83.1 million during the three months ended March 31, 2026, compared to $69.2 million during the three months ended March 31, 2025. The growth in revenue was primarily attributable to $72.0 million in revenue derived from the United States for the three mo…
Cost of sales increased $4.2 million, or 17%, to $29.2 million during the three months ended March 31, 2026, compared to $25.0 million during the three months ended March 31, 2025. The increase in cost of sales was primarily attributable to the growth in the number of units sold.
Gross margin increased to 65% during the three months ended March 31, 2026, compared to 64% for the three months ended March 31, 2025. The increase in gross margin was primarily attributable to the growth in unit sales, which allowed us to spread the fixed portion of our manufacturing overhead costs…
R&D expenses increased $5.1 million, or 31%, to $21.5 million during the three months ended March 31, 2026, compared to $16.4 million during the three months ended March 31, 2025. The increase in R&D expenses was primarily due to employee-related expenses of our R&D organization such as salaries and…
SG&A expenses increased $9.9 million, or 18%, to $65.1 million during the three months ended March 31, 2026, compared to $55.2 million during the three months ended March 31, 2025. The increase in SG&A expenses was primarily due to employee-related expenses of our sales and marketing organization su…
Legal proceedings
Text added vs the prior filing · source: 10-Q · 2026-08-05
On July 24, 2026, a putative securities class action complaint was filed in the U.S. District Court for the Northern District of California against us and certain of our current and former executive officers, captioned Operating Engineers Construction Industry and Miscellaneous Pension Fund v. PROCE…
The litigation is at an early stage, and we are unable to predict its outcome or reasonably estimate the amount or range of any potential loss. We believe that we have meritorious defenses and intend to defend the case vigorously. Failure to obtain a favorable resolution of this matter could have a …
In addition, from time to time, we may be involved in other legal proceedings arising in the ordinary course of our business. Regardless of outcome, litigation can have an adverse impact on us due to defense and settlement costs, diversion of management resources, negative publicity and reputation h…
Text removed vs the prior filing · source: 10-Q · 2026-04-30
From time to time, we may be involved in legal proceedings arising in the ordinary course of our business. We are not presently a party to any legal proceedings that, in the opinion of management, would have a material adverse effect on our business. Regardless of outcome, litigation can have an adv…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice